Samsung might remove the digitizer layer on the Galaxy Z Fold 7 to make it thinner, and to accommodate that, it could follow a stylus strategy similar to Apple.

Advocates say microdosing reduces costs and side effects while maintaining weight loss, then can help with weight maintenance ...

In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

Eli Lilly investors and analysts said they want to hear details from the company on how exactly it plans to grow U.S. sales ...

Arrogant Judge Stefan Mortensen (Rush) suffers a near-fatal stroke, leaving him partially paralyzed and confined to a ...

but has new data that could tip the balance in its favour. The results of the first head-to-head trial of Lilly's dual GLP-1/GIP agonist Zepbound (tirzepatide) and Novo Nordisk's GLP-1 agonist ...

Ultimate Artistic Versatility: Unleash your creativity with this comprehensive set of 48 dual-tip brush pens. The flexible brush tip allows for expressive strokes and calligraphy, while the fine ...

You will receive a combination of medication, meal plans, and behavioral tips to help you reach ... rather than as an auto-injector pen, also called a Zepbound pen. The vial doses available ...

The Food and Drug Administration approved Ozempic for treating patients with chronic kidney disease on Tuesday, marking the latest authorized use for Novo Nordisk’s popular drug known for ...

Eli Lilly and Co. reported that its FDA-approved weight-loss drug Zepbound (tirzepatide) outperformed Novo Nordisk A/S’s Wegovy (semaglutide) in the phase IIIb Surmount-5 trial.

Oprah Winfrey says taking a GLP-1 drug such as Ozempic and Wegovy has changed her entire perspective on “thin people.” A Type 2 diabetes medication that can also aid in weight loss, GLP-1 ...